The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Global Allergy Tester Market is experiencing steady expansion, supported by the increasing prevalence of allergic conditions, growing awareness of early diagnosis, and rising demand for accurate and accessible allergy testing solutions. Allergy testers help identify sensitivities to substances such as pollen, dust mites, food allergens, and other environmental triggers. These diagnostic...
The MiRNA Kits Market is gaining importance as molecular biology, genomics, and biomedical research continue to advance. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression and play important roles in various biological processes. MiRNA kits support the isolation, purification, detection, quantification, and analysis of these molecules in research and laboratory...
Global 3D Cell Culture Market Climbs from USD 1.80 Billion in 2025 toward USD 5.09 Billion by 2032, Expanding at an Accelerated 16.00% CAGR as Organoids, Microfluidic Organ-on-a-Chip Systems, and Non-Animal Testing Mandates Transform Preclinical Drug Discovery
Strategic Executive Intelligence on Scaffold-Based Hydrogels, Scaffold-Free Hanging Drop and Magnetic Levitation Platforms,...
Precision Analytics at the Core of Biopharma Innovation: Strategic Architecture and Growth Vector of the Global Bioanalytical Testing Services Market to 2034
Maximize Market Research has released its global strategic market study on the Global Bioanalytical Testing Services Market, offering an in-depth evaluation of pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity profiling,...
The nasopharyngeal cancer industry is witnessing significant advancements driven by evolving therapeutic options and enhanced diagnostic tools, resulting in robust market growth. Increasing prevalence driven by environmental and genetic factors is intensifying market dynamics, thereby contributing to lucrative industry trends and expanded market scope.Market Size and OverviewThe nasopharyngeal...
The pediatric brain tumors market is evolving rapidly with significant R&D breakthroughs driving market dynamics. Increasing incidence rates among younger populations and advancements in molecular diagnostics contribute to the expanding market scope, which demands a nuanced market analysis for effective market growth strategies.Market Size and Overview
The pediatric brain tumors market is...
The biliary tumor market is witnessing substantial transformation, driven by advancements in targeted therapies and diagnostic innovations. Industry trends emphasize growing investment in immunotherapies and precision medicine, shaping the competitive landscape and business growth opportunities for key market players.Market Size and Overview
The Global Biliary Tumor Market is estimated to be...
"According to the latest report published by Data Bridge Market Research, the Biopsy Guidance System Market
CAGR Value
The global Biopsy Guidance System market was valued at USD 1.58 billion in 2025 and is projected to reach USD 2.40 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033.
Getting thoughtful about competitive landscape is another significant aspect of...
Polaris Market Research releases its new research report on Non-Invasive Cancer Diagnostics market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive...
The market is expanding as life sciences organizations, clinical laboratories, software developers, and research institutions transition toward automated platforms that handle immense genomic datasets, lower sequencing interpretation costs, and accelerate therapeutic discovery. Growth is supported by the rapid accumulation of multi-omics data, public and private R&D funding, expanding...
Global Lab-on-a-Chip Market Set to Surpass USD 16.37 Billion Driven by Decentralized Point-of-Care Diagnostics, Microfluidic Drug Discovery, and Organ-on-Chip Breakthroughs
The international life sciences, clinical diagnostics, and biotechnology ecosystems are undergoing an architectural transition toward micro-scale operational integration. According to an extensive industry evaluation...
